(19)
(11) EP 4 770 659 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24861262.4

(22) Date of filing: 01.09.2024
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
C07K 19/00(2006.01)
A61P 9/06(2006.01)
C07K 14/05(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/06; C07K 14/723; A61K 38/00; C07K 2319/10
(86) International application number:
PCT/US2024/044936
(87) International publication number:
WO 2025/050091 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363580099 P

(71) Applicant: Ohio State Innovation Foundation
Columbus OH 43210 (US)

(72) Inventors:
  • EL REFAEY, Mona
    Columbus, Ohio 43210 (US)
  • MALHOTRA, Nipun
    Columbus, Ohio 43210 (US)

(74) Representative: Berggren Oy 
P.O. Box 16 Fabianinkatu 21
00101 Helsinki
00101 Helsinki (FI)

   


(54) THERAPEUTIC PEPTIDES TO MANAGE ATRIAL FIBRILLATION